Targeting microglial activation in stroke therapy: Pharmacological tools and gender effects

Current Medicinal Chemistry

Volumn 21, Issue 19, 2014, Pages 2146-2155

  Chen, Y ^a,b   Won, S J ^b   Xu, Y ^a   Swanson, R A ^b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; Corticosteroid; Female; HDAC; Inflammation; Ischemia; Minocycline; PARP

Indexed keywords

CHLORTETRACYCLINE; CORTICOSTEROID; DEMECLOCYCLINE; DOXYCYCLINE; HISTONE DEACETYLASE INHIBITOR; MINOCYCLINE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; RECEPTOR BLOCKING AGENT; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; CLINICAL STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENCEPHALITIS; HUMAN; MICROGLIA; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; SEX DIFFERENCE; TARGET CELL; TREATMENT RESPONSE; ANIMAL; IMMUNOLOGY; INFLAMMATION; SEXUAL DEVELOPMENT; STROKE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MICROGLIA; SEX CHARACTERISTICS; STROKE;

EID: 84899867952     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666131228203906     Document Type: Article

References (132)

1. Ginsberg, M.D., Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology, 2008, 55, (3)363-389.
2. Dirnagl, U.; Iadecola, C.; Moskowitz, M.A., Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci, 1999, 22, (9)391-397.
3. Kreutzberg, G.W., Microglia: a sensor for pathological events in the CNS. Trends Neurosci, 1996, 19, (8)312-318.
4. Kettenmann, H.; Hanisch, U.K.; Noda, M.; Verkhratsky, A., Physiology of microglia. Physiol Rev, 2011, 91, (2)461-553.
5. Stoll, G.; Jander, S.; Schroeter, M., Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol, 1998, 56, (2)149-171.
6. del Zoppo, G.J.; Frankowski, H.; Gu, Y.H.; Osada, T.; Kanazawa, M.; Milner, R.; Wang, X.; Hosomi, N.; Mabuchi, T.; Koziol, J.A., Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation. J Cereb Blood Flow Metab, 2012, 32, (5)919-932.
7. Block, M.L.; Zecca, L.; Hong, J.S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci, 2007, 8, (1)57-69.
8. Yenari, M.A.; Xu, L.; Tang, X.N.; Qiao, Y.; Giffard, R.G., Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke, 2006, 37, (4)1087-1093.
9. Yenari, M.A.; Kauppinen, T.M.; Swanson, R.A., Microglial activation in stroke: therapeutic targets. Neurotherapeutics, 2010, 7, (4)378-391.
10. Subramanian, S.; Zhang, B.; Kosaka, Y.; Burrows, G.G.; Grafe, M.R.; Vandenbark, A.A.; Hurn, P.D.; Offner, H., Recombinant T cell receptor ligand treats experimental stroke. Stroke, 2009, 40, (7)2539-2545.
11. Gelderblom, M.; Weymar, A.; Bernreuther, C.; Velden, J.; Arunachalam, P.; Steinbach, K.; Orthey, E.; Arumugam, T.V.; Leypoldt, F.; Simova, O.; Thom, V.; Friese, M.A.; Prinz, I.; Holscher, C.; Glatzel, M.; Korn, T.; Gerloff, C.; Tolosa, E.; Magnus, T., Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood, 2012, 120, (18)3793-3802.
12. McColl, B.W.; Rothwell, N.J.; Allan, S.M., Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin- 1- and neutrophil-dependent mechanisms. J Neurosci, 2007, 27, (16)4403-4412.
13. Chamorro, A.; Meisel, A.; Planas, A.M.; Urra, X.; van de Beek, D.; Veltkamp, R., The immunology of acute stroke. Nat Rev Neurol, 2012, 8, (7)401-410.
14. Ren, X.; Akiyoshi, K.; Dziennis, S.; Vandenbark, A.A.; Herson, P.S.; Hurn, P.D.; Offner, H., Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci, 2011, 31, (23)8556-8563.
15. Iadecola, C.; Anrather, J., The immunology of stroke: from mechanisms to translation. Nat Med, 2011, 17, (7)796-808.
16. Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H., Mechanisms underlying inflammation in neurodegeneration. Cell, 2010, 140, (6)918-934.
17. Cerqueira, S.R.; Oliveira, J.M.; Silva, N.A.; Leite-Almeida, H.; Ribeiro-Samy, S.; Almeida, A.; Mano, J.F.; Sousa, N.; Salgado, A.J.; Reis, R.L., Microglia Response and In Vivo Therapeutic Potential of Methylprednisolone- Loaded Dendrimer Nanoparticles in Spinal Cord Injury. Small, 2012.
18. Zhang, Z.; Artelt, M.; Burnet, M.; Schluesener, H.J., Dexamethasone attenuates early expression of three molecules associated with microglia/macrophages activation following rat traumatic brain injury. Acta Neuropathol, 2007, 113, (6)675-682.
19. Sugama, S.; Takenouchi, T.; Fujita, M.; Kitani, H.; Conti, B.; Hashimoto, M., Corticosteroids limit microglial activation occurring during acute stress. Neuroscience, 2012, 232C13-20.
20. McRae, A.; Bona, E.; Hagberg, H., Microglia-astrocyte interactions after cortisone treatment in a neonatal hypoxia-ischemia model. Brain Res Dev Brain Res, 1996, 94, (1)44-51.
21. Sapolsky, R.M., Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion. Stress, 1996, 1, (1)1-19.
22. Sorrells, S.F.; Caso, J.R.; Munhoz, C.D.; Sapolsky, R.M., The stressed CNS: when glucocorticoids aggravate inflammation. Neuron, 2009, 64, (1)33-39.
23. Sorrells, S.F.; Sapolsky, R.M., An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun, 2007, 21, (3)259-272.
24. Sandercock, P.A.; Soane, T., Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev, 2011, (9)CD000064.
25. Hoehn, B.D.; Palmer, T.D.; Steinberg, G.K., Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke, 2005, 36, (12)2718-2724.
26. Krishnakumar, R.; Kraus, W.L., The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell, 2010, 39, (1)8-24.
27. Ji, Y.; Tulin, A.V., The roles of PARP1 in gene control and cell differentiation. Curr Opin Genet Dev, 2010, 20, (5)512-518.
28. Chiarugi, A.; Moskowitz, M.A., Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem, 2003, 85, (2)306-317.
29. Ha, H.C.; Hester, L.D.; Snyder, S.H., Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A, 2002, 99, (5)3270-3275.
30. Kummar, S.; Ji, J.; Morgan, R.; Lenz, H.J.; Puhalla, S.L.; Belani, C.P.; Gandara, D.R.; Allen, D.; Kiesel, B.; Beumer, J.H.; Newman, E.M.; Rubinstein, L.; Chen, A.; Zhang, Y.; Wang, L.; Kinders, R.J.; Parchment, R.E.; Tomaszewski, J.E.; Doroshow, J.H., A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas. Clin Cancer Res, 2012, 18, (6)1726-1734.
31. Kauppinen, T.M.; Swanson, R.A., Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol, 2005, 174, (4)2288-2296.
32. Hamby, A.M.; Suh, S.W.; Kauppinen, T.M.; Swanson, R.A., Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke, 2007, 38, (2 Suppl)632-636.
33. Kauppinen, T.M.; Suh, S.W.; Berman, A.E.; Hamby, A.M.; Swanson, R.A., Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J Cereb Blood Flow Metab, 2009, 29, (4)820-829.
34. Endres, M.; Wang, Z.Q.; Namura, S.; Waeber, C.; Moskowitz, M.A., Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab, 1997, 17, (11)1143-1151.
35. Takahashi, K.; Greenberg, J.H.; Jackson, P.; Maclin, K.; Zhang, J., Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab, 1997, 17, (11)1137-1142.
36. Koh, D.W.; Dawson, T.M.; Dawson, V.L., Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res, 2005, 52, (1)5-14.
37. Won, S.J.; Suh, S.W.; Swanson, R.A., The effect of post-treatment with the PARP inhibitor, INO-1001 on glial activation and neuronal death after transient focal cerebral ischemia. Soc Neuroscience Abstr, 2011, 460.10.
38. Yrjanheikki, J.; Tikka, T.; Keinanen, R.; Goldsteins, G.; Chan, P.H.; Koistinaho, J., A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A, 1999, 96, (23)13496-13500.
39. Tikka, T.M.; Koistinaho, J.E., Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol, 2001, 166, (12)7527-7533.
40. Suk, K., Minocycline suppresses hypoxic activation of rodent microglia in culture. Neurosci Lett, 2004, 366, (2)167-171.
41. Kobayashi, K.; Imagama, S.; Ohgomori, T.; Hirano, K.; Uchimura, K.; Sakamoto, K.; Hirakawa, A.; Takeuchi, H.; Suzumura, A.; Ishiguro, N.; Kadomatsu, K., Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis, 2013, 4e525.
42. Yrjanheikki, J.; Keinanen, R.; Pellikka, M.; Hokfelt, T.; Koistinaho, J., Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A, 1998, 95, (26)15769-15774.
43. Wixey, J.A.; Reinebrant, H.E.; Carty, M.L.; Buller, K.M., Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain. J Neuroimmunol, 2009, 212, (1-2)35-43.
44. Wixey, J.A.; Reinebrant, H.E.; Spencer, S.J.; Buller, K.M., Efficacy of post-insult minocycline administration to alter long-term hypoxia-ischemia- induced damage to the serotonergic system in the immature rat brain. Neuroscience, 2011, 182184-192.
45. Arvin, K.L.; Han, B.H.; Du, Y.; Lin, S.Z.; Paul, S.M.; Holtzman, D.M., Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol, 2002, 52, (1)54-61.
46. Xu, L.; Fagan, S.C.; Waller, J.L.; Edwards, D.; Borlongan, C.V.; Zheng, J.; Hill, W.D.; Feuerstein, G.; Hess, D.C., Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol, 2004, 47.
47. Jiang, S.X.; Lertvorachon, J.; Hou, S.T.; Konishi, Y.; Webster, J.; Mealing, G.; Brunette, E.; Tauskela, J.; Preston, E., Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia. J Biol Chem, 2005, 280, (40)33811-33818.
48. Wang, J.; Wei, Q.; Wang, C.Y.; Hill, W.D.; Hess, D.C.; Dong, Z., Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem, 2004, 279, (19)19948-19954.
49. Fernandez-Gomez, F.J.; Galindo, M.F.; Gomez-Lazaro, M.; Gonzalez-Garcia, C.; Cena, V.; Aguirre, N.; Jordan, J., Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions. Neuroscience, 2005, 133, (4)959-967.
50. Zhu, S.; Stavrovskaya, I.G.; Drozda, M.; Kim, B.Y.; Ona, V.; Li, M.; Sarang, S.; Liu, A.S.; Hartley, D.M.; Wu, D.C.; Gullans, S.; Ferrante, R.J.; Przedborski, S.; Kristal, B.S.; Friedlander, R.M., Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 2002, 417, (6884)74-78.
51. Wang, X.; Zhu, S.; Drozda, M.; Zhang, W.; Stavrovskaya, I.G.; Cattaneo, E.; Ferrante, R.J.; Kristal, B.S.; Friedlander, R.M., Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci U S A, 2003, 100, (18)10483-10487.
52. Kraus, R.L.; Pasieczny, R.; Lariosa-Willingham, K.; Turner, M.S.; Jiang, A.; Trauger, J.W., Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radicalscavenging activity. J Neurochem, 2005, 94, (3)819-827.
53. Nikodemova, M.; Duncan, I.D.; Watters, J.J., Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J Neurochem, 2006, 96, (2)314-323.
54. Pi, R.; Li, W.; Lee, N.T.; Chan, H.H.; Pu, Y.; Chan, L.N.; Sucher, N.J.; Chang, D.C.; Li, M.; Han, Y., Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. J Neurochem, 2004, 91, (5)1219-1230.
55. Alano, C.C.; Kauppinen, T.M.; Valls, A.V.; Swanson, R.A., Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A, 2006, 103, (25)9685-9690.
56. Hayakawa, K.; Mishima, K.; Nozako, M.; Hazekawa, M.; Mishima, S.; Fujioka, M.; Orito, K.; Egashira, N.; Iwasaki, K.; Fujiwara, M., Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a highmobility group box1-inhibiting mechanism. Stroke, 2008, 39, (3)951-958.
57. Liu, Z.; Fan, Y.; Won, S.J.; Neumann, M.; Hu, D.; Zhou, L.; Weinstein, P.R.; Liu, J., Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke, 2007, 38, (1)146-152.
58. Fagan, S.C.; Waller, J.L.; Nichols, F.T.; Edwards, D.J.; Pettigrew, L.C.; Clark, W.M.; Hall, C.E.; Switzer, J.A.; Ergul, A.; Hess, D.C., Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke, 2010, 41, (10)2283-2287.
59. Lampl, Y.; Boaz, M.; Gilad, R.; Lorberboym, M.; Dabby, R.; Rapoport, A.; Anca-Hershkowitz, M.; Sadeh, M., Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology, 2007, 69, (14)1404-1410.
60. Thiagalingam, S.; Cheng, K.H.; Lee, H.J.; Mineva, N.; Thiagalingam, A.; Ponte, J.F., Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci, 2003, 98384-100.
61. Matsuoka, H.; Fujimura, T.; Hayashi, M.; Matsuda, K.; Ishii, Y.; Aramori, I.; Mutoh, S., Disruption of HDAC4/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression. Biochem Pharmacol, 2007, 74, (3)465-476.
62. Georgopoulos, K., From immunity to tolerance through HDAC. Nat Immunol, 2009, 10, (1)13-14.
63. Grausenburger, R.; Bilic, I.; Boucheron, N.; Zupkovitz, G.; El-Housseiny, L.; Tschismarov, R.; Zhang, Y.; Rembold, M.; Gaisberger, M.; Hartl, A.; Epstein, M.M.; Matthias, P.; Seiser, C.; Ellmeier, W., Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production. J Immunol, 2010, 185, (6)3489-3497.
64. Lundh, M.; Christensen, D.P.; Rasmussen, D.N.; Mascagni, P.; Dinarello, C.A.; Billestrup, N.; Grunnet, L.G.; Mandrup-Poulsen, T., Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines. Diabetologia, 2010, 53, (12)2569-2578.
65. Marumo, T.; Hishikawa, K.; Yoshikawa, M.; Hirahashi, J.; Kawachi, S.; Fujita, T., Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol, 2010, 298, (1)F133-141.
66. Ito, K.; Hanazawa, T.; Tomita, K.; Barnes, P.J.; Adcock, I.M., Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Bioph Res Co, 2004, 315, (1)240-245.
67. Faraco, G.; Pittelli, M.; Cavone, L.; Fossati, S.; Porcu, M.; Mascagni, P.; Fossati, G.; Moroni, F.; Chiarugi, A., Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiol Dis, 2009, 36, (2)269-279.
68. Chuang, D.M.; Leng, Y.; Marinova, Z.; Kim, H.J.; Chiu, C.T., Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci, 2009, 32, (11)591-601.
69. Gibson, C.L.; Murphy, S.P., Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. J Neurochem, 2010, 115, (4)806-813.
70. Faraco, G.; Pancani, T.; Formentini, L.; Mascagni, P.; Fossati, G.; Leoni, F.; Moroni, F.; Chiarugi, A., Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol, 2006, 70, (6)1876-1884.
71. Ren, M.; Leng, Y.; Jeong, M.; Leeds, P.R.; Chuang, D.M., Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem, 2004, 89, (6)1358-1367.
72. Kim, H.J.; Rowe, M.; Ren, M.; Hong, J.S.; Chen, P.S.; Chuang, D.M., Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther, 2007, 321, (3)892-901.
73. Vecsey, C.G.; Hawk, J.D.; Lattal, K.M.; Stein, J.M.; Fabian, S.A.; Attner, M.A.; Cabrera, S.M.; McDonough, C.B.; Brindle, P.K.; Abel, T.; Wood, M.A., Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci, 2007, 27, (23)6128-6140.
74. Guan, J.S.; Haggarty, S.J.; Giacometti, E.; Dannenberg, J.H.; Joseph, N.; Gao, J.; Nieland, T.J.; Zhou, Y.; Wang, X.; Mazitschek, R.; Bradner, J.E.; DePinho, R.A.; Jaenisch, R.; Tsai, L.H., HDAC2 negatively regulates memory formation and synaptic plasticity. Nature, 2009, 459, (7243)55-60.
75. Kim, M.S.; Akhtar, M.W.; Adachi, M.; Mahgoub, M.; Bassel-Duby, R.; Kavalali, E.T.; Olson, E.N.; Monteggia, L.M., An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci, 2012, 32, (32)10879-10886.
76. Bardai, F.H.; D'Mello, S.R., Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta. J Neurosci, 2011, 31, (5)1746-1751.
77. Kazantsev, A.G.; Thompson, L.M., Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov, 2008, 7, (10)854-868.
78. Lehnardt, S.; Lehmann, S.; Kaul, D.; Tschimmel, K.; Hoffmann, O.; Cho, S.; Krueger, C.; Nitsch, R.; Meisel, A.; Weber, J.R., Tolllike receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol, 2007, 190, (1-2)28-33.
79. Brea, D.; Blanco, M.; Ramos-Cabrer, P.; Moldes, O.; Arias, S.; Perez-Mato, M.; Leira, R.; Sobrino, T.; Castillo, J., Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J Cereb Blood Flow Metab, 2011, 31, (6)1424-1431.
80. Abe, T.; Shimamura, M.; Jackman, K.; Kurinami, H.; Anrather, J.; Zhou, P.; Iadecola, C., Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke, 2010, 41, (5)898-904.
81. Kunz, A.; Abe, T.; Hochrainer, K.; Shimamura, M.; Anrather, J.; Racchumi, G.; Zhou, P.; Iadecola, C., Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J Neurosci, 2008, 28, (7)1649-1658.
82. Cho, S.; Park, E.M.; Febbraio, M.; Anrather, J.; Park, L.; Racchumi, G.; Silverstein, R.L.; Iadecola, C., The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J Neurosci, 2005, 25, (10)2504-2512.
83. Cho, S.; Szeto, H.H.; Kim, E.; Kim, H.; Tolhurst, A.T.; Pinto, J.T., A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem, 2007, 282, (7)4634-4642.
84. Gregersen, R.; Lambertsen, K.; Finsen, B., Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab, 2000, 20, (1)53-65.
85. Botchkina, G.I.; Meistrell, M.E., 3rd; Botchkina, I.L.; Tracey, K.J., Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med, 1997, 3, (11)765-781.
86. Shohami, E.; Ginis, I.; Hallenbeck, J.M., Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev, 1999, 10, (2)119-130.
87. Yoon, J.S.; Lee, J.H.; Tweedie, D.; Mughal, M.R.; Chigurupati, S.; Greig, N.H.; Mattson, M.P., 3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation. J Neurosci Res, 2013, 91, (5)671-680.
88. Hosomi, N.; Ban, C.R.; Naya, T.; Takahashi, T.; Guo, P.; Song, X.Y.; Kohno, M., Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab, 2005, 25, (8)959-967.
89. Lavine, S.D.; Hofman, F.M.; Zlokovic, B.V., Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J Cereb Blood Flow Metab, 1998, 18, (1)52-58.
90. Barone, F.C.; Arvin, B.; White, R.F.; Miller, A.; Webb, C.L.; Willette, R.N.; Lysko, P.G.; Feuerstein, G.Z., Tumor necrosis factoralpha. A mediator of focal ischemic brain injury. Stroke, 1997, 28, (6)1233-1244.
91. Sumbria, R.K.; Boado, R.J.; Pardridge, W.M., Brain protection from stroke with intravenous TNFalpha decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab, 2012, 32, (10)1933-1938.
92. Heldmann, U.; Thored, P.; Claasen, J.H.; Arvidsson, A.; Kokaia, Z.; Lindvall, O., TNF-alpha antibody infusion impairs survival of stroke-generated neuroblasts in adult rat brain. Exp Neurol, 2005, 196, (1)204-208.
93. McCoy, M.K.; Tansey, M.G., TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation, 2008, 545.
94. Hurn, P.D.; Macrae, I.M., Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab, 2000, 20, (4)631-652.
95. Yuan, M.; Siegel, C.; Zeng, Z.; Li, J.; Liu, F.; McCullough, L.D., Sex differences in the response to activation of the poly (ADPribose) polymerase pathway after experimental stroke. Exp Neurol, 2009, 217, (1)210-218.
96. Roof, R.L.; Hall, E.D., Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma, 2000, 17, (5)367-388.
97. Phoenix, C.H.; Goy, R.W.; Gerall, A.A.; Young, W.C., Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology, 1959, 65369-382.
98. Schwarz, J.M.; Sholar, P.W.; Bilbo, S.D., Sex differences in microglial colonization of the developing rat brain. J Neurochem, 2012, 120, (6)948-963.
99. Elzer, J.G.; Muhammad, S.; Wintermantel, T.M.; Regnier-Vigouroux, A.; Ludwig, J.; Schutz, G.; Schwaninger, M., Neuronal estrogen receptor-alpha mediates neuroprotection by 17betaestradiol. J Cereb Blood Flow Metab, 2010, 30, (5)935-942.
100. Arevalo, M.A.; Santos-Galindo, M.; Acaz-Fonseca, E.; Azcoitia, I.; Garcia-Segura, L.M., Gonadal hormones and the control of reactive gliosis. Horm Behav, 2013, 63, (2)216-221.
101. Bruce-Keller, A.J.; Keeling, J.L.; Keller, J.N.; Huang, F.F.; Camondola, S.; Mattson, M.P., Antiinflammatory effects of estrogen on microglial activation. Endocrinology, 2000, 141, (10)3646-3656.
102. Mann, S.A.; Versmold, B.; Marx, R.; Stahlhofen, S.; Dietzel, I.D.; Heumann, R.; Berger, R., Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats. J Neuroinflammation, 2008, 539.
103. Du, L.; Bayir, H.; Lai, Y.; Zhang, X.; Kochanek, P.M.; Watkins, S.C.; Graham, S.H.; Clark, R.S., Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem, 2004, 279, (37)38563-38570.
104. Jiang, C.; Cui, K.; Wang, J.; He, Y., Microglia and cyclooxygenase-2: possible therapeutic targets of progesterone for stroke. Int Immunopharmacol, 2011, 11, (11)1925-1931.
105. Muller, E.; Kerschbaum, H.H., Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPSinduced NO release in the murine microglial cell line, BV-2. Neuro Endocrinol Lett, 2006, 27, (5)675-678.
106. Drew, P.D.; Chavis, J.A., Female sex steroids: effects upon microglial cell activation. J Neuroimmunol, 2000, 111, (1-2)77-85.
107. Baker, A.E.; Brautigam, V.M.; Watters, J.J., Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology, 2004, 145, (11)5021-5032.
108. Brait, V.H.; Jackman, K.A.; Walduck, A.K.; Selemidis, S.; Diep, H.; Mast, A.E.; Guida, E.; Broughton, B.R.; Drummond, G.R.; Sobey, C.G., Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab, 2010, 30, (7)1306-1317.
109. Johann, S.; Beyer, C., Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J Steroid Biochem Mol Biol, 2013, 137, (1)39-45.
110. Wood, H., Neuroimmunology: estrogen receptor ligands suppress inflammatory responses in astrocytes and microglia. Nat Rev Neurol, 2011, 7, (7)355.
111. Crain, J.M.; Watters, J.J., Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection. Open Drug Discov J, 2010, 2148-167.
112. Dang, J.; Mitkari, B.; Kipp, M.; Beyer, C., Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun, 2011, 25, (4)715-726.
113. McCullough, L.D.; Zeng, Z.; Blizzard, K.K.; Debchoudhury, I.; Hurn, P.D., Ischemic nitric oxide and poly (ADP-ribose) polymerase- 1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab, 2005, 25, (4)502-512.
114. Li, J.; McCullough, L.D., Sex differences in minocycline-induced neuroprotection after experimental stroke. J Cereb Blood Flow Metab, 2009, 29, (4)670-674.
115. Hagberg, H.; Wilson, M.A.; Matsushita, H.; Zhu, C.; Lange, M.; Gustavsson, M.; Poitras, M.F.; Dawson, T.M.; Dawson, V.L.; Northington, F.; Johnston, M.V., PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem, 2004, 90, (5)1068-1075.
116. Liu, F.; Lang, J.; Li, J.; Benashski, S.E.; Siegel, M.; Xu, Y.; McCullough, L.D., Sex differences in the response to poly(ADPribose) polymerase-1 deletion and caspase inhibition after stroke. Stroke, 2011, 42, (4)1090-1096.
117. Won, S.J.; Suh, S.W.; Kauppinen, T.M.; Yoo, B.H.; Swanson, R.A., PARP-1 inhibition blocks ischemia-induced microglial activation in male but not female rats. Soc Neuroscience Abstr, 2010, 152.8.
118. Mabley, J.G.; Horvath, E.M.; Murthy, K.G.; Zsengeller, Z.; Vaslin, A.; Benko, R.; Kollai, M.; Szabo, C., Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J Pharmacol Exp Ther, 2005, 315, (2)812-820.
119. Ransohoff, R.M.; Perry, V.H., Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol, 2009, 27119-145.
120. Carson, M.J.; Bilousova, T.V.; Puntambekar, S.S.; Melchior, B.; Doose, J.M.; Ethell, I.M., A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics, 2007, 4, (4)571-579.
121. Michelucci, A.; Heurtaux, T.; Grandbarbe, L.; Morga, E.; Heuschling, P., Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol, 2009, 210, (1-2)3-12.
122. Sica, A.; Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J Clin Invest, 2012, 122, (3)787-795.
123. Hu, X.; Li, P.; Guo, Y.; Wang, H.; Leak, R.K.; Chen, S.; Gao, Y.; Chen, J., Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke, 2012, 43, (11)3063-3070.
124. Belmadani, A.; Tran, P.B.; Ren, D.; Miller, R.J., Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci, 2006, 26, (12)3182-3191.
125. Eyo, U.B.; Dailey, M.E., Microglia: Key Elements in Neural Development, Plasticity, and Pathology. J Neuroimmune Pharmacol, 2013, 8, (3)494-509.
126. Madinier, A.; Bertrand, N.; Mossiat, C.; Prigent-Tessier, A.; Beley, A.; Marie, C.; Garnier, P., Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One, 2009, 4, (12)e8101.
127. Zhao, B.Q.; Wang, S.; Kim, H.Y.; Storrie, H.; Rosen, B.R.; Mooney, D.J.; Wang, X.; Lo, E.H., Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med, 2006, 12, (4)441-445.
128. Fox, C.; Dingman, A.; Derugin, N.; Wendland, M.F.; Manabat, C.; Ji, S.; Ferriero, D.M.; Vexler, Z.S., Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab, 2005, 25, (9)1138-1149.
129. Chu, L.S.; Fang, S.H.; Zhou, Y.; Yu, G.L.; Wang, M.L.; Zhang, W.P.; Wei, E.Q., Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats. Acta Pharmacol Sin, 2007, 28, (6)763-772.
130. Carty, M.L.; Wixey, J.A.; Colditz, P.B.; Buller, K.M., Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. Int J Dev Neurosci, 2008, 26, (5)477-485.
131. Hayakawa, K.; Irie, K.; Sano, K.; Watanabe, T.; Higuchi, S.; Enoki, M.; Nakano, T.; Harada, K.; Ishikane, S.; Ikeda, T.; Fujioka, M.; Orito, K.; Iwasaki, K.; Mishima, K.; Fujiwara, M., Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism. Biol Pharm Bull, 2009, 32, (9)1538-1544.
132. Xuan, A.; Long, D.; Li, J.; Ji, W.; Hong, L.; Zhang, M.; Zhang, W., Neuroprotective effects of valproic acid following transient global ischemia in rats. Life Sci, 2012, 90, (11-12)463-468.